Literature DB >> 18722389

Endocannabinoid signaling in microglial cells.

Nephi Stella1.   

Abstract

The endocannabinoid signaling system (eCBSS) is composed of cannabinoid (CB) receptors, their endogenous ligands (the endocannabinoids, eCB) and the enzymes that produce and inactivate these ligands. Neurons use this signaling system to communicate with each other and Delta9-tetrahydrocannabinol (THC), the main psychotropic ingredient of Cannabis sativa, induces profound behavioral effects by impinging on this communication. Evidence now shows that microglia, the macrophages of the brain, also express a functional eCBSS and that activation of CB receptors expressed by activated microglia controls their immune-related functions. This review summarizes this evidence, discusses how microglia might use the eCBSS to communicate with each other and neighboring cells, and argues that compounds selectively targeting the eCBSS expressed by microglia constitute valuable therapeutics to manage acute and chronic neuroinflammation, without inducing the psychotropic effects and underlying addictive properties commonly associated with THC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722389      PMCID: PMC2654419          DOI: 10.1016/j.neuropharm.2008.07.037

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  144 in total

1.  Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.

Authors:  Alexander F Hoffman; Alice M Macgill; Dennison Smith; Murat Oz; Carl R Lupica
Journal:  Eur J Neurosci       Date:  2005-11       Impact factor: 3.386

Review 2.  Like cops on the beat: the active role of resting microglia.

Authors:  Gennadij Raivich
Journal:  Trends Neurosci       Date:  2005-09-13       Impact factor: 13.837

3.  Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice.

Authors:  Lynsey G Bilsland; James R T Dick; Gareth Pryce; Stefania Petrosino; Vincenzo Di Marzo; David Baker; Linda Greensmith
Journal:  FASEB J       Date:  2006-03-29       Impact factor: 5.191

4.  Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection.

Authors:  Anke Witting; Lanfen Chen; Eiron Cudaback; Alex Straiker; Lisa Walter; Barry Rickman; Thomas Möller; Celia Brosnan; Nephi Stella
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-29       Impact factor: 11.205

5.  BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain.

Authors:  Jeffrey A M Coull; Simon Beggs; Dominic Boudreau; Dominick Boivin; Makoto Tsuda; Kazuhide Inoue; Claude Gravel; Michael W Salter; Yves De Koninck
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

6.  Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.

Authors:  G Gobbi; F R Bambico; R Mangieri; M Bortolato; P Campolongo; M Solinas; T Cassano; M G Morgese; G Debonnel; A Duranti; A Tontini; G Tarzia; M Mor; V Trezza; S R Goldberg; V Cuomo; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-13       Impact factor: 11.205

7.  The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.

Authors:  Eva Eljaschewitsch; Anke Witting; Christian Mawrin; Thomas Lee; Peter M Schmidt; Susanne Wolf; Heide Hoertnagl; Cedric S Raine; Regine Schneider-Stock; Robert Nitsch; Oliver Ullrich
Journal:  Neuron       Date:  2006-01-05       Impact factor: 17.173

8.  The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.

Authors:  Yoshinobu Kawamura; Masahiro Fukaya; Takashi Maejima; Takayuki Yoshida; Eriko Miura; Masahiko Watanabe; Takako Ohno-Shosaku; Masanobu Kano
Journal:  J Neurosci       Date:  2006-03-15       Impact factor: 6.167

9.  Cannabinoid CB2 receptors: immunohistochemical localization in rat brain.

Authors:  Jian-Ping Gong; Emmanuel S Onaivi; Hiroki Ishiguro; Qing-Rong Liu; Patricia A Tagliaferro; Alicia Brusco; George R Uhl
Journal:  Brain Res       Date:  2006-02-09       Impact factor: 3.252

10.  COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.

Authors:  Yiangos Yiangou; Paul Facer; Pascal Durrenberger; Iain P Chessell; Alan Naylor; Chas Bountra; Richard R Banati; Praveen Anand
Journal:  BMC Neurol       Date:  2006-03-02       Impact factor: 2.474

View more
  100 in total

Review 1.  Neuroinflammation in Huntington's disease.

Authors:  Thomas Möller
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

2.  CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling.

Authors:  Javier Palazuelos; Zaira Ortega; Javier Díaz-Alonso; Manuel Guzmán; Ismael Galve-Roperh
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

3.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

4.  The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release.

Authors:  Monica Bari; Tiziana Bonifacino; Marco Milanese; Paola Spagnuolo; Simona Zappettini; Natalia Battista; Francesco Giribaldi; Cesare Usai; Giambattista Bonanno; Mauro Maccarrone
Journal:  Cell Mol Life Sci       Date:  2010-08-15       Impact factor: 9.261

5.  Two novel mutations in ABHD12: expansion of the mutation spectrum in PHARC and assessment of their functional effects.

Authors:  Dong-Hui Chen; Alipi Naydenov; Jacqueline L Blankman; Heather C Mefford; Marie Davis; Youngmee Sul; A Samuel Barloon; Emily Bonkowski; John Wolff; Mark Matsushita; Corrine Smith; Benjamin F Cravatt; Ken Mackie; Wendy H Raskind; Nephi Stella; Thomas D Bird
Journal:  Hum Mutat       Date:  2013-10-02       Impact factor: 4.878

6.  Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro.

Authors:  Emelie Janefjord; Jesper L V Mååg; Benjamin S Harvey; Scott D Smid
Journal:  Cell Mol Neurobiol       Date:  2013-09-13       Impact factor: 5.046

Review 7.  Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles.

Authors:  Claudia Verderio; Martina Gabrielli; Paola Giussani
Journal:  J Lipid Res       Date:  2018-05-31       Impact factor: 5.922

Review 8.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

Review 9.  Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies.

Authors:  Milky Kohno; Jeanne Link; Laura E Dennis; Holly McCready; Marilyn Huckans; William F Hoffman; Jennifer M Loftis
Journal:  Pharmacol Biochem Behav       Date:  2019-01-26       Impact factor: 3.533

10.  Active endocannabinoids are secreted on extracellular membrane vesicles.

Authors:  Martina Gabrielli; Natalia Battista; Loredana Riganti; Ilaria Prada; Flavia Antonucci; Laura Cantone; Michela Matteoli; Mauro Maccarrone; Claudia Verderio
Journal:  EMBO Rep       Date:  2015-01-07       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.